Synapse Cardiovascular (Synapse CV). Software Versions: 6.0 to 6.2.1 The Synapse Cardiovascula...

FDA Device Recall #Z-1775-2021 — Class II — April 30, 2021

Recall Summary

Recall Number Z-1775-2021
Classification Class II — Moderate risk
Date Initiated April 30, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Fujifilm Medical Systems U.S.A., Inc.
Location Lexington, MA
Product Type Devices
Quantity 44 US and 4 OUS

Product Description

Synapse Cardiovascular (Synapse CV). Software Versions: 6.0 to 6.2.1 The Synapse Cardiovascular image is a management and reporting system

Reason for Recall

Software versions 6.0.4 to 6.2.1 using Advanced Reporting -possibility that a previously assigned internal patient database ID can be reused for a new patient. It was discovered that this value does not increase when a patient merge activity is executed in a specific sequence

Distribution Pattern

Worldwide distribution - US Nationwide distribution and the countries of Canada, Bermuda, Israel, Hadassah Medical Center.

Lot / Code Information

Software Versions: 6.0 to 6.2.1

Other Recalls from Fujifilm Medical Systems U.S.A., Inc.

Recall # Classification Product Date
Z-1348-2021 Class II Synapse PACS - Radiological Image Processing Sy... Mar 2, 2021
Z-1412-2021 Class II ¿TASWako Chip Cassette is part of the Wako ¿TAS... Feb 18, 2021
Z-0932-2021 Class III Wako HDL-C/LDL-C Calibrator - Product Usage: de... Dec 22, 2020
Z-0918-2021 Class II FUJIFILM Synapse PACS Software: versions 7.0.0 ... Dec 11, 2020
Z-0282-2021 Class II Synapse PACS Software Version 5.6.1 - Product U... Sep 11, 2020

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.